Sökning: id:"swepub:oai:lup.lub.lu.se:987d792b-545b-4030-af2e-fce2f57ec898" >
Prediction of Mild ...
Prediction of Mild Cognitive Impairment that Evolves into Alzheimer's Disease Dementia within Two Years using a Gene Expression Signature in Blood: A Pilot Study
-
Roed, Line (författare)
-
Grave, Gisle (författare)
-
Lindahl, Torbjorn (författare)
-
visa fler...
-
Rian, Edith (författare)
-
Horndalsveen, Peter O. (författare)
-
- Lannfelt, Lars (författare)
- Uppsala universitet,Geriatrik,molekylär geriatrik/ rudbecklaboratoriet
-
- Nilsson, Christer (författare)
- Lund University,Lunds universitet,Psykiatri, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Psychiatry (Lund),Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine
-
Swenson, Frank (författare)
-
Lonneborg, Anders (författare)
-
Sharma, Praveen (författare)
-
Sjogren, Magnus (författare)
-
visa färre...
-
(creator_code:org_t)
- 2013
- 2013
- Engelska.
-
Ingår i: Journal of Alzheimer's Disease. - 1387-2877 .- 1875-8908. ; 35:3, s. 611-621
- Relaterad länk:
-
https://portal.resea... (primary) (free)
-
visa fler...
-
http://dx.doi.org/10...
-
https://uu.diva-port... (primary) (Raw object)
-
https://lup.lub.lu.s...
-
https://doi.org/10.3...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: The focus on Alzheimer's disease (AD) is shifting from dementia to the prodromal stage of the disorder, to a large extent due to increasing efforts in trying to develop disease modifying treatment for the disorder. For development of disease-modifying drugs, a reliable and accurate test for identification of mild cognitive impairment (MCI) due to AD is essential. Objective: In the present study, MCI progressing to AD will be predicted using blood-based gene expression. Material and Methods: Gene expression analysis using qPCR was performed on blood RNA from a cohort of patients with amnestic MCI (aMCI; n = 66). Within the aMCI cohort, patients progressing to AD within 1 to 2 years were grouped as MCI converters (n = 34) and the patients remaining at the MCI stage after 2 years were grouped as stable MCI (n = 32). AD and control populations were also included in the study. Results: Multivariate statistical method partial least square regression was used to develop predictive models which later were tested using leave-one-out cross validation. Gene expression signatures that identified aMCI subjects that progressed to AD within 2 years with a prediction accuracy of 74%-77% were identified for the complete dataset and subsets thereof. Conclusion: The present pilot study demonstrates for the first time that MCI that evolves into AD dementia within 2 years may be predicted by analyzing gene expression in blood. Further studies will be needed to validate this gene signature as a potential test for AD in the predementia stage.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Nyckelord
- Alzheimer's disease
- biomarkers
- diagnostic tests
- gene expression
- signatures
- mild cognitive impairment
- Alzheimer's disease
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Roed, Line
-
Grave, Gisle
-
Lindahl, Torbjor ...
-
Rian, Edith
-
Horndalsveen, Pe ...
-
Lannfelt, Lars
-
visa fler...
-
Nilsson, Christe ...
-
Swenson, Frank
-
Lonneborg, Ander ...
-
Sharma, Praveen
-
Sjogren, Magnus
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Journal of Alzhe ...
- Av lärosätet
-
Lunds universitet
-
Uppsala universitet